LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Centinel Spine Adds Seasoned Sales Team
People In The News

Centinel Spine Adds Seasoned Sales Team

February 8, 2011 1 min read Premium comments

Advertisement

Centinel Spine Adds Seasoned Sales Team
Centinel Spine

Centinel Spine announced at the end of January the expansion of the company’s sales team.

Bill Pfost and Dan Martin are, respectively, the new National VP of Sales and Area VP of Sales.

John Viscogliosi, Centinel’s chairman and CEO said while the company’s sales growth was “strong and steady” in 2010, he was confident the addition of the new sales team will be a catalyst “for exponential sales growth in 2011 and beyond.”

Pfost was most recently VP of New Business Development at Lanx. He has 25 years of medical device sales and management experience with 10 years at U.S. Surgical. He was subsequently affiliated with Spine Tech/Zimmer Spine as an assistant VP and then served as president of that entity’s Spine Distribution Group.

Martin, with 26 years of experience in device sales, spent 15 years in the spine sector as a Sales Specialist at DePuy Motech Spine. He was also Regional Sales Director at Surgical Dynamics, VP of Sales at Theken and VP of Regional Development for Signus Medical.

Centinel Spine was founded in 2008 from the roots of Raymedica to design and develop biomechanical solutions for spinal stabilization and fusion.

The company announced a 41.8% increase in revenue from the third to the fourth quarter in 2010 as the company initiated its new STALIF Midline alpha launch.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy